Original Research
Published on 08 Feb 2023
Potentially inappropriate medication among older patients with diabetic kidney disease
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1098465
- 2,047 views
Type at least 3 characters
1,947 articles
Articles
Editorial
Published on 08 Feb 2023
Editorial: Recent advances in attempts to improve medication adherence-from basic research to clinical practice
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1144662
- 2,338 views
- 2 citations
Original Research
Published on 07 Feb 2023
Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1080073
- 2,522 views
- 5 citations
Original Research
Published on 07 Feb 2023
Translation and validation of the medication management patient satisfaction survey: The Lebanese Arabic version
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.997103
- 1,666 views
Systematic Review
Published on 06 Feb 2023
The use of remimazolam versus propofol for induction and maintenance of general anesthesia: A systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1101728
- 9,952 views
- 40 citations
Original Research
Published on 02 Feb 2023
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1125576
- 20,192 views
- 18 citations
Original Research
Published on 02 Feb 2023
Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1088900
- 5,413 views
- 7 citations
Clinical Trial
Published on 01 Feb 2023
14-day pantoprazole- and amoxicillin-containing high-dose dual therapy for Helicobacter pylori eradication in elderly patients: A prospective, randomized controlled trial
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1096103
- 25,942 views
- 8 citations
Original Research
Published on 30 Jan 2023
A pharmacist-led medication review service with a deprescribing focus guided by implementation science
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1097238
- 4,930 views
- 3 citations
Policy and Practice Reviews
Published on 26 Jan 2023
Orphan drugs’ clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1074512
- 5,937 views
- 4 citations
Original Research
Published on 26 Jan 2023
Immune checkpoint inhibitor-induced aplastic anaemia: Case series and large-scale pharmacovigilance analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1057134
- 4,950 views
- 2 citations
Systematic Review
Published on 25 Jan 2023
The effect of antibiotics on the periodontal treatment of diabetic patients with periodontitis: A systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1013958
- 3,766 views
- 4 citations
Review
Published on 23 Jan 2023
Bibliometric analysis and evidence of clinical efficacy and safety of digital pills
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1023250
- 4,852 views
- 2 citations
Systematic Review
Published on 20 Jan 2023
A systematic review and Bayesian meta-analysis of the antibiotic treatment courses in AECOPD
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1024807
- 2,655 views
- 3 citations
Systematic Review
Published on 20 Jan 2023
Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: A systematic review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1046306
- 2,470 views
- 6 citations
Opinion
Published on 20 Jan 2023
Rational use of drugs for the elderly during the COVID-19 pandemic in China: Challenges and opportunities
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1106144
- 1,190 views
- 1 citation